| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adherence measures and their utility
|
Dunbar, Jacqueline
|
|
1984
|
5 |
4 |
p. 515-521
7 p.
|
artikel
|
| 2 |
Alternative adherence marker schemes
|
Fales, Henry M.
|
|
1984
|
5 |
4 |
p. 576-578
3 p.
|
artikel
|
| 3 |
Appendix: List of actual and potential adherence markers and devices
|
|
|
1984
|
5 |
4 |
p. 584-587
4 p.
|
artikel
|
| 4 |
Behavioral aspects of the use of medical markers in clinical trials
|
Russell, Michael L.
|
|
1984
|
5 |
4 |
p. 526-534
9 p.
|
artikel
|
| 5 |
Chemical analysis of marker substances
|
Maickel, Roger P.
|
|
1984
|
5 |
4 |
p. 556-567
12 p.
|
artikel
|
| 6 |
Clinical pharmacology of a marker of patient compulsiveness
|
Leigh Thompson, W.
|
|
1984
|
5 |
4 |
p. 522-525
4 p.
|
artikel
|
| 7 |
Development of assays for drugs of abuse
|
Willette, Robert E.
|
|
1984
|
5 |
4 |
p. 466-471
6 p.
|
artikel
|
| 8 |
Evaluation and recommendations for adherence marker development by working groups of the workshop
|
Insull Jr., William
|
|
1984
|
5 |
4 |
p. 579-583
5 p.
|
artikel
|
| 9 |
Food and drug administration's requirements for markers
|
Tocus, Edward C.
|
|
1984
|
5 |
4 |
p. 463-465
3 p.
|
artikel
|
| 10 |
General concepts for use of markers in clinical trials
|
Gordis, Leon
|
|
1984
|
5 |
4 |
p. 481-487
7 p.
|
artikel
|
| 11 |
Historical review: Comparison with other methods
|
Roth, Harold P.
|
|
1984
|
5 |
4 |
p. 476-480
5 p.
|
artikel
|
| 12 |
Issues in medication adherence assessment in clinical trials of the National Heart, Lung, and Blood Institute
|
Mattson, Margaret E.
|
|
1984
|
5 |
4 |
p. 488-496
9 p.
|
artikel
|
| 13 |
Monitoring compliance through analysis of drug and metabolite levels
|
Mollica, Joseph A.
|
|
1984
|
5 |
4 |
p. 505-514
10 p.
|
artikel
|
| 14 |
Preface
|
Friedewald, William T.
|
|
1984
|
5 |
4 |
p. ix-
1 p.
|
artikel
|
| 15 |
Riboflavin use as a drug marker in Veterans Administration Cooperative Studies
|
Young, Larry M.
|
|
1984
|
5 |
4 |
p. 497-504
8 p.
|
artikel
|
| 16 |
Stable isotopic abundances as reflections of ingestion practices
|
Klein, Peter D.
|
|
1984
|
5 |
4 |
p. 568-572
5 p.
|
artikel
|
| 17 |
Statement of the problem and pharmacological and clinical requirements for the ideal marker
|
Insull Jr., William
|
|
1984
|
5 |
4 |
p. 459-462
4 p.
|
artikel
|
| 18 |
The potential use of markers in drug development
|
Tempero, Kenneth F.
|
|
1984
|
5 |
4 |
p. 535-539
5 p.
|
artikel
|
| 19 |
The Statistical analysis of adherence data obtained from markers
|
Silvers, Abraham
|
|
1984
|
5 |
4 |
p. 544-555
12 p.
|
artikel
|
| 20 |
Tracer microspheres as compliance markers in clinical research
|
Wolen, Robert L.
|
|
1984
|
5 |
4 |
p. 540-543
4 p.
|
artikel
|
| 21 |
United States department of agriculture's requirements for markers
|
Hibbert, Robert G.
|
|
1984
|
5 |
4 |
p. 472-475
4 p.
|
artikel
|
| 22 |
Use of stable isotopes to determine compliance
|
Schwarcz, Henry P.
|
|
1984
|
5 |
4 |
p. 573-575
3 p.
|
artikel
|
| 23 |
Workshop summary
|
Insull Jr., William
|
|
1984
|
5 |
4 |
p. 451-458
8 p.
|
artikel
|
Tijdschrift beschrijving